FDI proposals worth Rs 1,075.91 cr cleared; Glenmark, Aurobindo sent to CCEA

Last Updated: Thursday, February 19, 2015, 21:13

FIPB has cleared foreign investment in 11 entities, entailing Rs 1,075.91 crore, and referred proposals worth Rs 4,187 crore in pharma firms - Glenmark and Aurobindo - to the Cabinet Committee on Economic Affairs.

Glenmark bullish on drug discovery pipeline, eyes partnerships

Last Updated: Sunday, February 15, 2015, 20:55

As many as six out of seven molecules in Glenmark's drug discovery pipeline are currently in the clinical trial stage and the company's R&D spend pegged at 10 percent of sales is expected to be maintained at similar levels for next two years, a top official has said.

Glenmark bullish on drug discovery pipeline, eyes partnerships

Last Updated: Sunday, February 15, 2015, 11:00

Pain, inflammation and oncology are the therapeutic areas currently the drug maker is working on, said Glenn Saldanha, Chairman & Managing Director, Glenmark Pharmaceuticals Ltd.

Glenmark Q3 net dips 47 pc at Rs 114.77 cr

Last Updated: Thursday, February 12, 2015, 19:23

Glenmark Pharmaceuticals today reported a 46.92 per cent dip in its consolidated net profit at Rs 114.77 crore for the quarter ended December 31, 2014 mainly due to forex losses and increased expenses.

HC sets aside restraint on Glenmark from making an antibiotic

Last Updated: Thursday, February 5, 2015, 15:32

Delhi High Court today set aside its single judge's order restraining Mumbai-based generic drug maker Glenmark Pharmaceuticals Ltd from making and selling its antibiotic medicine Linezolid.

Glenmark faces patent infringement suit for cancer drug in US

Last Updated: Tuesday, December 31, 2013, 14:33

Glenmark Pharmaceuticals has been slapped with a patent infringement case by US-based Cephalon Inc over plans to sell generic version of leukaemia treatment drug Treanda in the American market.

Glenmark Pharma Q2 net down 1.565 at Rs 154.29 cr

Last Updated: Thursday, October 31, 2013, 19:16

Glenmark Pharmaceuticals Thursday reported a 1.56 percent dip in its consolidated net profit at Rs 154.29 crore for the quarter ended September 30, 2013 mainly on account of increased taxes.

Glenmark gets USFDA nod for skin infections cream

Last Updated: Monday, September 30, 2013, 15:36

Glenmark Pharmaceuticals on Monday said it has received approval from the US health regulator for its generic Hydrocortisone Butyrate Cream used for treating variety of skin infections.

Glenmark gets research fee payment from Forest Laboratories

Last Updated: Friday, September 27, 2013, 16:10

The company, however, did not disclose the exact quantum of payment.

Glenmark gets USFDA nod for alcohol abstinence drug

Last Updated: Monday, August 12, 2013, 12:39

GGL is a subsidiary of Mumbai-based Glenmark Pharmaceuticals Ltd.

Glenmark Q1 net profit up 64% at Rs 128.67 cr

Last Updated: Thursday, August 1, 2013, 20:05

Drug firm Glenmark Pharmaceuticals Thursday reported a 64.39 percent rise in its consolidated net profit at Rs 128.67 crore for the first quarter ended June 30, 2013 mainly on account of robust sales.

MSD-Glenmark drug patent row: Delhi HC reserves verdict

Last Updated: Thursday, August 1, 2013, 16:59

The Delhi High Court on Thursday reserved its verdict on US drug major Merck Sharp and Dohme's (MSD) appeal against a single judge bench order refusing to restrain Indian firm Glenmark from manufacturing and selling anti-diabetes drugs Zita and Zita-Met.